Octaplasma solution: exposed to temperatures outside of the recommended storage conditions
Brand(s)
Last updated
Summary
Product
Octaplasma solution
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
Octapharma |
Octaplasma Solution |
DIN 02270013 |
Solution |
Human plasma proteins 14g/200mL |
M337C9521 |
Issue
Affected lot distributed in some Newfoundland hospitals may have been exposed to temperatures outside of the recommended storage conditions.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Hospitals
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Biologic or vaccine
Companies
Recalling firm:
Canadian Blood Services
1800 Alta Vista Drive,
Ottawa, ON K1G 4J5
Market Authorization Holder:
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
Oberlaaer Strasse 235,
Vienna, Vienne, Austria A-1100
Published by
Health Canada
Audience
General public
Healthcare
Hospitals
Recall class
Type III
Identification number
RA-75541
History
Change log
2024-05-22: Reason for recall
Get notified
Receive notifications for new and updated recalls and alerts by category.